{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:44:14Z","timestamp":1792035854668,"version":"4.4.0"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.antiviral.2016.10.014","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T21:32:16Z","timestamp":1478035936000},"page":"23-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Meeting report: 29th International Conference on Antiviral Research in La Jolla, CA, USA"],"prefix":"10.1016","volume":"137","author":[{"given":"R. Anthony","family":"Vere Hodge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.10.014_bib1","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciw571","article-title":"Clinical and virological characteristics of Ebola virus disease patients treated with favipiravir (T-705), Sierra Leone, 2014","author":"Bai","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"21","key":"10.1016\/j.antiviral.2016.10.014_bib2","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1056\/NEJMoa1413275","article-title":"Activity of oral ALS-008176 in a respiratory syncytial virus challenge study","volume":"373","author":"DeVincenzo","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"4899","key":"10.1016\/j.antiviral.2016.10.014_bib3","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1126\/science.2467383","article-title":"HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy","volume":"243","author":"Larder","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.10.014_bib4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/272583a0","article-title":"9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group","volume":"272","author":"Schaffer","year":"1978","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.antiviral.2016.10.014_bib5","doi-asserted-by":"crossref","first-page":"e1001967","DOI":"10.1371\/journal.pmed.1001967","article-title":"Experimental treatment with favipiravir for ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea","volume":"13","author":"Sissoko","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.antiviral.2016.10.014_bib6","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJMoa1604330","article-title":"A\u00a0Randomized, controlled trial of ZMapp for ebola virus infection","volume":"375","author":"The PREVAIL II Writing Group, for the Multi-National PREVAIL II Study Team","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.10.014_bib7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.antiviral.2015.09.015","article-title":"Meeting report: 28th International Conference on antiviral research in Rome, Italy","volume":"123","author":"Vere Hodge","year":"2015","journal-title":"Antivir. Res."},{"issue":"4618","key":"10.1016\/j.antiviral.2016.10.014_bib8","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1126\/science.6684328","article-title":"Carbocyclic arabinofuranosyladenine (cyclaradine): efficacy against genital herpes in Guinea pigs","volume":"221","author":"Vince","year":"1983","journal-title":"Science"},{"issue":"8481","key":"10.1016\/j.antiviral.2016.10.014_bib9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(86)92808-4","article-title":"Administration of 3\u2032-azido-3\u2032-deoxythymidine, an inhibitor of HTLV-III\/LAV replication, to patients with AIDS or AIDS-related complex","volume":"327","author":"Yarchoan","year":"1986","journal-title":"Lancet"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216306428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216306428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T21:58:44Z","timestamp":1536271124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216306428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":9,"alternative-id":["S0166354216306428"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.10.014","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meeting report: 29th International Conference on Antiviral Research in La Jolla, CA, USA","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}